A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Pricing in the Market for Anticancer Drugs
2015
Journal of Economic Perspectives
Preserved Fulltext
Questions • Have the benefit-adjusted launch prices of anticancer drugs increased over time? • If so, why? Outline • The market for anticancer drugs: not a competitive market • Data on pricing trends: prices are going up, not related to benefits • Speculative theories on pricing behavior: reference price models of demand and growth of discounts.
doi:10.1257/jep.29.1.139
fatcat:riz55yaa7nfcfpiwxxkgckxeom